Mark Duplass Says ‘Obsession’ And ‘Backrooms’ Box Office Wins Offer A “Glimmer Of Hope” In “Fractured” Industry

Backrooms and Obsession are emerging as breakout box office successes, with Backrooms reaching $118 million worldwide and Obsession hitting $104.7 million in the U.S. and $148 million globally despite a sub-$1 million production budget. The films are outperforming larger releases and reinforcing the viability of low-cost, creator-led filmmaking distributed through online audiences. The article frames this as a positive signal for the horror genre and for studios looking for scalable, high-return content.

Analysis

The signal here is less about two individual hits and more about a structural re-rating of the low-budget horror/IP acquisition model. If audiences continue rewarding creator-led concepts that can be produced cheaply and scaled globally, the marginal economics shift toward distributors that can source volume through social-native talent rather than expensive tentpole development. That favors studios with disciplined marketing and strong genre pipelines, while increasing pressure on legacy franchises that require larger P&A to get to the same level of consumer attention.

Second-order, this is a capital-allocation story for the entire supply chain. Expect a faster bidding market for YouTube-native creators, practical-effects vendors, post houses, and mid-tier agencies that can package “audience-proven” concepts, which may compress returns for smaller indie financiers but improve hit rates for platforms able to underwrite dozens of micro-bets. The bigger implication is that discovery is becoming cheaper than distribution, which should advantage firms with owned marketing channels and disadvantage those reliant on broad theatrical awareness campaigns.

For DIS, the read-through is nuanced: not a direct earnings catalyst, but supportive of theatrical and genre-content economics if the market starts rewarding lower-cost, higher-conviction slates. The risk is that this remains a narrow genre phenomenon; if over-extrapolated, capital could chase a few outliers and bid up acquisition costs faster than the success rate improves. The key test over the next 1-2 quarters is whether this model persists across multiple releases and whether studios materially change greenlight behavior, not whether these two films merely cleared a high hurdle.

Contrarian view: the market may be underestimating how much of this is a distribution/arbitrage win rather than a broad demand renaissance. If social-native filmmakers are simply delivering pre-sold audiences, the economic moat sits with audience capture, not with studio brands; that means the real winners could be talent platforms and creator tools more than traditional film owners. If the next wave of imitators underperform, sentiment could reverse quickly and the trade becomes a short-lived narrative spike rather than a durable industry shift.

Key Decisions for Investors

• Long selected genre-distribution leaders on any post-weekend pullback: favor companies with lean acquisition models and proven horror monetization over broad-content studios; horizon 3-6 months, target 15-20% upside if the creator-led pipeline sustains.
• Pair trade: long BXMT/creator-economy-adjacent media infrastructure winners, short capital-intensive legacy content names that depend on large P&A budgets; use 6-12 weeks as the initial catalyst window around slate announcements.
• For DIS, stay neutral-to-slightly constructive via call spreads only on weakness; the setup is a second-order benefit, not a standalone thesis, so risk/reward is better expressed with limited-premium structures than outright stock.
• Watch for a follow-on acquisition binge in indie horror over the next 1-2 quarters; if M&A pricing starts to expand, fade the move by shorting the most expensive small-cap content acquirers versus a basket of self-funded creators.
• Consider a long position in picks-and-shovels creative tools/software exposure on any retracement, since democratized production is the most durable theme here and can compound over 12-24 months independent of box office volatility.